| |
|
|
|
|
|
|
|||
|
M Kobayashi, M Imamura, Y Gotohda, S Maeda, H Iwasaki, K Sakurada, M Kasai, AJ Hapel and T Miyazaki
Third Department of Internal Medicine, Hokkaido University School of
Medicine, Sapporo, Japan.
In the present study, we show that recombinant human interleukin-1 beta
(rhIL-1 beta), which has no effect on the proliferation of human progenitor
cells, has synergistic effects on the expansion of human progenitor cells
induced by rhIL-3 in liquid cultures. The synergistic effects of rhIL-1
beta with rhIL-3 were observed in liquid cultures using not only fresh bone
marrow mononuclear cells, but also selected populations of nonadherent
cells, non-T nonadherent cells, and CD34- positive cells.
Anti-granulocyte-macrophage colony-stimulating factor (anti-GM-CSF)
antibody partially blocked the synergistic effects of rhIL-1 beta on the
proliferation of colony-forming unit (CFU)-GM burst- forming unit-erythroid
(BFU-E), and CFU-Mix in liquid cultures in the presence of rhIL-1 beta plus
rhIL-3, suggesting that the synergistic effects of rhIL-1 beta plus rhIL-3
are explained in part by the secondary production of GM-CSF. Limiting
dilution assays and liquid culture assays using CD34-positive cells
indicate that rhIL-1 beta directly increases the numbers of colony-forming
cells in liquid cultures. These results suggest that rhIL-1 beta has unique
direct and indirect effects on the expansion of hematopoietic progenitor
cells in liquid cultures.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1991 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||